News Image

Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio

Provided By GlobeNewswire

Last update: Dec 11, 2025

Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection

• Portfolio includes tests for colorectal disease, breast self exam, prostate disease, kidney disease, and H. pylori infection

Read more at globenewswire.com

BIOMERICA INC

NASDAQ:BMRA (12/12/2025, 8:16:25 PM)

2.58

0 (0%)



Find more stocks in the Stock Screener

Follow ChartMill for more